CPAP vs HFNC in treatment of patients with COVID-19 ARDS: A retrospective propensity-matched study
Canadian Journal of Respiratory Therapy · 31.10.2024 · 60
DOI: 10.29390/001c.125145 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Respiratory Therapy, online erschienen am 31.10.2024. Verfasst von Ivan Šitum und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Reanimatology, Intensive Medicine and Pain Therapy University Hospital Centre Zagreb. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Previous studies exploring the application of noninvasive ventilation or high-flow nasal cannula in patients with COVID-19-related acute respiratory distress syndrome (ARDS) have yielded conflicting results on whether any method of respiratory support is superior. Our aim is to compare the efficacy and safety of respiratory therapy with high-flow nasal cannula and noninvasive ventilation with continuous positive airway pressure in treatment of COVID-19-related ARDS.
Methods
This is a retrospective cohort study based on data from patients who received respiratory support as part of their treatment in the COVID intensive care unit at the University Hospital Centre Zagreb between February 2021 and February 2023. Using propensity score analysis, 42 patients treated with high-flow nasal cannula (HFNC group) were compared to 42 patients treated with noninvasive ventilation with continuous positive airway pressure (CPAP group). Primary outcome was intubation rate.
Results
Intubation rate was 71.4% (30/42) in the HFNC group and 40.5% (17/42) in the CPAP group ( p = 0.004). Hazard ratio for intubation was 3.676 (95% confidence interval [CI] 1.480 to 9.232) with the HFNC versus CPAP group. Marginally significant difference in survival between the two groups was observed at 30 days ( p = 0.050) but was statistically significant at 60 days ( p = 0.043).
Conclusions
Respiratory support with high-flow nasal cannula and noninvasive ventilation with continuous positive airway pressure yielded significantly different intubation rates in favour of continuous positive airway pressure. The same patients also had better 30-day and 60-day survival post-admission.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, Reanimatology, Intensive Medicine and Pain Therapy University Hospital Centre Zagreb.
- Department of Emergency Medicine University Hospital Centre Zagreb.
- Department of Cardiology University Hospital Centre Zagreb.
Zitieren
APA
Šitum, I., Hrvoić, L., Erceg, A., Mandarić, A., Karmelić, D., Mamić, G., Džaja, N., Babić, A., Mihaljević, S., Mažar, M., & Lovrić, D. (2024). CPAP vs HFNC in treatment of patients with COVID-19 ARDS: A retrospective propensity-matched study. Canadian Journal of Respiratory Therapy, 60. https://doi.org/10.29390/001c.125145
Vancouver
Šitum I, Hrvoić L, Erceg A, Mandarić A, Karmelić D, Mamić G, et al. CPAP vs HFNC in treatment of patients with COVID-19 ARDS: A retrospective propensity-matched study. Canadian Journal of Respiratory Therapy. 2024;60. doi:10.29390/001c.125145
BibTeX
@article{itum2024,
author = {Šitum, Ivan and Hrvoić, Lovro and Erceg, Ante and Mandarić, Anja and Karmelić, Dora and Mamić, Gloria and Džaja, Nikolina and Babić, Anđela and Mihaljević, Slobodan and Mažar, Mirabel and Lovrić, Daniel},
title = {CPAP vs HFNC in treatment of patients with COVID-19 ARDS: A retrospective propensity-matched study},
journal = {Canadian Journal of Respiratory Therapy},
year = {2024},
volume = {60},
doi = {10.29390/001c.125145}
}
EUVIMED